His primary areas of study are Internal medicine, Endocrinology, Homocysteine, Framingham Heart Study and Risk factor. His study in Framingham Risk Score, Body mass index, Metabolic syndrome, Cohort study and C-reactive protein is carried out as part of his studies in Internal medicine. His Framingham Risk Score course of study focuses on Offspring and Fortification.
His study in Homocysteine is interdisciplinary in nature, drawing from both Heart disease, Cardiology, Surgery and National Health and Nutrition Examination Survey. His work deals with themes such as Logistic regression, Blood pressure, Isoflavones, Proportional hazards model and Hazard ratio, which intersect with Framingham Heart Study. His biological study spans a wide range of topics, including Blood lipids, Bone density, Prospective cohort study and Blood serum.
His scientific interests lie mostly in Internal medicine, Endocrinology, Framingham Heart Study, Homocysteine and Framingham Risk Score. His study in Internal medicine focuses on Vitamin, Risk factor, Cohort, Body mass index and Hyperhomocysteinemia. In his study, which falls under the umbrella issue of Cohort, Stroke and Lower risk is strongly linked to Prospective cohort study.
His Framingham Heart Study research is multidisciplinary, incorporating perspectives in Obesity, Gerontology, Cohort study, Cardiology and Physiology. In his study, Odds ratio is strongly linked to Surgery, which falls under the umbrella field of Homocysteine. His Framingham Risk Score research incorporates elements of Offspring and Proportional hazards model.
Paul F. Jacques mainly investigates Internal medicine, Framingham Heart Study, Framingham Risk Score, Offspring and Cohort. Paul F. Jacques has researched Internal medicine in several fields, including Gastroenterology and Endocrinology. In Framingham Heart Study, Paul F. Jacques works on issues like Gerontology, which are connected to Dementia, Diabetes mellitus and Observational study.
His Framingham Risk Score study incorporates themes from Body mass index, Cancer and Physiology. His work in Offspring addresses issues such as Obesity, which are connected to fields such as Type 2 diabetes and Circadian rhythm. His work carried out in the field of Cohort brings together such families of science as Prospective cohort study, Proportional hazards model and Confounding.
The scientist’s investigation covers issues in Internal medicine, Framingham Heart Study, Prospective cohort study, Cohort study and Offspring. Paul F. Jacques interconnects Gastroenterology, Diabetes mellitus, Endocrinology and Linoleic acid in the investigation of issues within Internal medicine. His Endocrinology study is mostly concerned with Obesity and Homocysteine.
His Framingham Heart Study research integrates issues from Odds ratio, Oxidative stress, Food science, Dementia and Physical therapy. His Prospective cohort study research is multidisciplinary, relying on both Cohort, Environmental health, Lower risk, Stroke and Snacking. As part of the same scientific family, he usually focuses on Offspring, concentrating on Framingham Risk Score and intersecting with Body mass index.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Sudha Seshadri;Alexa Beiser;Jacob Selhub;Paul F Jacques.
The New England Journal of Medicine (2002)
Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935.
Aviva Must;Paul F. Jacques;Gerard E. Dallal;Carl J. Bajema.
The New England Journal of Medicine (1992)
Vitamin D Deficiency and Risk of Cardiovascular Disease
Thomas J. Wang;Michael J. Pencina;Sarah L. Booth;Paul F. Jacques.
Circulation (2008)
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Jacob Selhub;Paul F. Jacques;Peter W. F. Wilson;David Rush.
JAMA (1993)
Metabolite profiles and the risk of developing diabetes
Thomas J Wang;Martin G Larson;Martin G Larson;Ramachandran S Vasan;Ramachandran S Vasan;Susan Cheng;Susan Cheng;Susan Cheng.
Nature Medicine (2011)
Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
R. Clarke;R. Collins;S. Lewington;A. Donald.
JAMA (2002)
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
Thomas J. Wang;Feng Zhang;J. Brent Richards;Bryan Kestenbaum.
The Lancet (2010)
Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations
P. F. Jacques;A. G. Bostom;R. R. Williams;R. C. Ellison.
Circulation (1996)
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Jacob Selhub;Paul F. Jacques;Andrew G. Bostom;Ralph B. D'Agostino.
The New England Journal of Medicine (1995)
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Thomas J. Wang;Philimon Gona;Philimon Gona;Martin G. Larson;Martin G. Larson;Geoffrey H. Tofler.
The New England Journal of Medicine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Tufts University
Tufts University
Boston University
Harvard University
Tufts University
Wake Forest University
Tufts University
Emory University
Tufts University
Vanderbilt University
University of Malaga
Zhejiang University
École des Ponts ParisTech
École Polytechnique
McGill University Health Centre
University of California, Los Angeles
University of Tromsø - The Arctic University of Norway
Institute of Environmental Geology and Geoengineering
K.E. Percy Air Quality Effects Consulting Ltd
United States Department of Agriculture
University of Parma
University of Illinois at Urbana-Champaign
Osaka University
University of Pavia
Eötvös Loránd University
SLAC National Accelerator Laboratory